toxin injection has been a common option to manage spasticity in children with cerebral palsy (CP). Multi-level injections are recommended based on the fact that most patients have diffuse spasticity rather than focal spasticity.
No takes yet. Share an insight, caveat, or question.
Teerada Ploypetch (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: